Baseline characteristics and vitreoretinal interface features in patients with vitreomacular traction associated with macular hole from the MIVI-TRUST clinical program

    loading  Checking for direct PDF access through Ovid



There is limited published evidence on demographic and vitreoretinal interface (VRI) characteristics of patients with vitreomacular traction in association with macular hole (VMT+MH). Establishing insights into the characteristics of untreated VMT+MH may contribute to a better understanding of the burden of VMT disease To describe baseline patient characteristics and VRI features in patients with VMT+MH included in the phase 3 ocriplasmin studies


Two randomized, double-masked, placebo-controlled trials designed to determine efficacy and safety of ocriplasmin for the treatment of VMT comprising 652 patients. Key baseline characteristics included patient demographics (age, gender); eye-disorder (time since VMT diagnosis, visual acuity (VA) study eye (SE); non-study eye (NSE), pseudophakia and/or ERM); VRI features (MH width; vitreous separation), VFQ-25 composite score


VMT+MH was present in 153 patients (23.5%). Baseline characteristics were: 68.7 years (SD 7.1); 75.8% female. Time since diagnosis: 62 days (SD 131); VA: SE 55.9 (SD 10.5), NSE 77.8 (SD 14.3). Pseudophakes: 20.9%, concomitant ERM: 15.8%. Min-max hole width: 272.7 (SD 127.7), vitreous adhesions attached at fovea and optic nerve (89.5%); VFQ-25 composite score: 80.3 (SD 14.6)


This analysis reports baseline characteristics of patients with VMT+MH, which can be used to demonstrate differences in VMT patients without MH

Related Topics

    loading  Loading Related Articles